Divis Laboratories Fact Sheet, Divis Laboratories Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Divis Laboratories Fact Sheet    (DIVI)


Going LIVE Today at 5pm: Our Special Event on India's Revival


Here is the latest financial fact sheet of Divis Laboratories. For more details, see the Divis Laboratories quarterly results and Divis Laboratories share price and chart. For a sector overview, read our pharmaceuticals sector report.

DIVIS LABORATORIES Price History

Price Rs 3,758.4
Mkt Cap Rs m 997,735
Vol '000 34.4
P/E X 53.7
P/CF X 65.6
EPS (TTM) Rs 70.0
% ch % 1.0
No. of shares m 265.47
% ch week % 4.0
% ch 1-mth % 7.0
% ch 12-mth % 60.6
52 week H/L Rs 3,913.0/2,094.6
(As on Apr 15, 2021 02:36:00 PM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

DIVIS LABORATORIES Financials

No. of Mths
Year Ending
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
5-Yr Chart
Click to enlarge
DIVIS LABORATORIES EQUITY SHARE DATA
High Rs1,8812,4841,2221,1421,639 
Low Rs1,2179187845331,115 
Sales per share (Unadj.) Rs234.7142.3153.1146.6186.3 
Earnings per share (Unadj.) Rs64.242.439.933.051.0 
Diluted earnings per shareRs32.142.439.933.051.0 
Cash flow per share (Unadj.) Rs74.446.944.638.457.3 
Dividends per share (Unadj.) Rs20.0010.0010.0010.0016.00 
Adj. dividends per shareRs10.0010.0010.0010.0016.00 
Dividend yield (eoy) %1.30.61.01.21.2 
Book value per share (Unadj.) Rs288.0161.7201.8222.8261.8 
Adj. book value per shareRs144.0161.7201.8222.8261.8 
Shares outstanding (eoy) m132.73265.47265.47265.47265.47 
Bonus/Rights/Conversions  ----- 
Price / Sales ratio x6.612.06.65.77.4 
Avg P/E ratio x24.140.125.125.327.0 
P/CF ratio (eoy) x20.836.322.521.824.0 
Price / Book Value ratio x5.410.55.03.85.3 
Dividend payout %31.223.625.030.331.4 
Avg Mkt Cap Rs m205,599451,525266,266222,318365,592 
No. of employees `0008.79.59.710.811.8 
Total wages/salary Rs m2,9043,6124,9994,5615,423 
Avg. sales/employee Rs Th3,571.83,983.14,175.03,616.04,175.1 
Avg. wages/employee Rs Th333.0381.0513.5423.8457.7 
Avg. net profit/employee Rs Th976.41,187.41,089.3814.91,141.8 
DIVIS LABORATORIES INCOME DATA
Net Sales Rs m31,14937,76440,64338,91549,463 
Other income Rs m4479747491,1341,556 
Total revenues Rs m31,59638,73841,39240,04951,019 
Gross profit Rs m11,65214,17414,46012,61718,718 
Depreciation Rs m1,3601,1821,2331,4251,689 
Interest Rs m1938231335 
Profit before tax Rs m10,72113,92813,95312,31318,551 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m2,2062,6713,3493,5435,023 
Profit after tax Rs m8,51511,25810,6048,77013,527 
Gross profit margin %37.437.535.632.437.8 
Effective tax rate %20.619.224.028.827.1 
Net profit margin %27.329.826.122.527.3 
DIVIS LABORATORIES BALANCE SHEET DATA
Current assets Rs m27,72430,27040,10545,35146,501 
Current liabilities Rs m4,5605,1956,5956,5348,468 
Net working cap to sales %74.466.482.599.776.9 
Current ratio x6.15.86.16.95.5 
Inventory Days Days136117119127131 
Debtors Days Days8785819586 
Net fixed assets Rs m15,23116,99819,99521,16025,797 
Share capital Rs m266531531531531 
"Free" reserves Rs m37,95842,40253,04358,62568,962 
Net worth Rs m38,22342,93353,57459,15669,493 
Long term debt Rs m115000 
Total assets Rs m43,82949,02161,58567,85980,383 
Interest coverage x577.4369.5618.4926.8531.0 
Debt to equity ratio x00000 
Sales to assets ratio x0.70.80.70.60.6 
Return on assets %19.523.017.312.916.9 
Return on equity %22.326.219.814.819.5 
Return on capital %28.132.526.120.826.7 
Exports to sales %84.385.3000 
Imports to sales %23.922.925.221.824.6 
Exports (fob) Rs m26,24432,198000 
Imports (cif) Rs m7,4428,65410,2608,48512,187 
Fx inflow Rs m26,31732,27035,38432,35941,238 
Fx outflow Rs m7,5888,77510,3999,04212,405 
Net fx Rs m18,72923,49624,98523,31728,833 
DIVIS LABORATORIES CASH FLOW
From Operations Rs m 8,263 10,379 11,504 7,759 9,543 
From Investments Rs m -5,208 -4,064 -11,396 -4,783 -6,854 
From Financial Activity Rs m -3,030 -6,311 24 -3,142 -2,459 
Net Cashflow Rs m 25 3 132 -166 230 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 52.0%
Foreign collaborators 0.0%
Indian inst/Mut Fund 11.8%
FIIs 19.0%
ADR/GDR 0.0%
Free float 17.2%
Shareholders 31,796
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF 7-1-77/E/1/303, Divi Towers, Dharam Karan Road, Ameerpet, Hyderabad-16
E-MAIL cs@divislaboratories.com WEB www.divislaboratories.com
TELEPHONE (040) 2378 6300 FAX (040) 2378 6460
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Karvy Computershare, 17-24, Vithalrao Nagar, Madhapur, Hyderabad-81
AUDITOR P. V. R. K. Nageswara Rao & Co.
CHM: Murali K. Divi (MD) COMP SEC: P. V. Lakshmi Rajani YEAR OF INC: 1990 BSE CODE: 532488 FV (Rs): 2 DIV YIELD (%): 0.4

Read: DIVIS LABORATORIES 2018-19 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   GSK PHARMA  FDC  AMAR REMEDIES  LUPIN  FRESENIUS KABI ONCO.  

Compare DIVIS LABORATORIES With:   GSK PHARMA  FDC  AMAR REMEDIES  LUPIN  FRESENIUS KABI ONCO.  

Compare DIVIS LABORATORIES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  




Today's Market

Sensex Trades Over 300 Points Lower, Dow Futures Up by 99 Points(12:30 pm)

Share markets in India are presently trading on a negative note. The BSE Sensex is trading down by 304 points, down 0.6% at 48,240 levels.

Views on news

DIVIS LABORATORIES Announces Quarterly Results (3QFY21); Net Profit Up 27.9% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, DIVIS LABORATORIES has posted a net profit of Rs 5 bn (up 27.9% YoY). Sales on the other hand came in at Rs 17 bn (up 19.1% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (1QFY21); Net Profit Up 84.1% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, DIVIS LABORATORIES has posted a net profit of Rs 5 bn (up 84.1% YoY). Sales on the other hand came in at Rs 17 bn (up 50.0% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES 2018-19 Annual Report Analysis (Annual Result Update)

Oct 10, 2019 | Updated on Oct 10, 2019

Here's an analysis of the annual report of DIVIS LABORATORIES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games? (The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave (Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

An India Revival Stock I'm Bullish On... (Profit Hunter)

Apr 9, 2021

This could take India to the position of 3rd largest economy.

Why Did the Market Crash on Monday? (Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

Why the Market Fell Yesterday (Fast Profits Daily)

Apr 6, 2021

In this video, I'll tell you the two reasons why the market fell on Monday and how you can prepare yourself for such events in the future.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

TRACK DIVIS LABORATORIES

  • Track your investment in DIVIS LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DIVIS LABORATORIES

DIVIS LABORATORIES - PIRAMAL ENTERPRISES COMPARISON

COMPARE DIVIS LABORATORIES WITH

MARKET STATS